Schedule 13G ownership disclosure
ANI Pharmaceuticals Inc
Security class unavailable · CUSIP: 00182C103
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,070,224
- Percent of class
- 9.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000215457-17-001265
- Form type
- SC 13G
- Filer
- ANI PHARMACEUTICALS INC
- CIK
- CIK 1023024
- Filed
- Jan 19, 2017
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership